We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
OSI Systems
OSIS
$3.57B
| $706K | 0.01% |
+9,100
| New | +$679K |
|
|
SRNE
1202
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $704K | 0.01% |
63,175
+52,950
| +518% | +$485K |
|
1203
Blackstone
BX
$104B
| $694K | 0.01% |
13,300
-5,200
| -28% | -$278K |
|
|
CVGW
1204
DELISTED
Calavo Growers
CVGW
| $694K | 0.01% |
10,474
+4,356
| +71% | +$274K |
|
1205
CALL
Autodesk
ADSK
$44.3B
| $693K | 0.01% |
+3,000
| New | +$713K |
|
|
1206
PUT
Autodesk
ADSK
$44.3B
| $693K | 0.01% |
+3,000
| New | +$713K |
|
1207
Avanos Medical
AVNS
$1.17B
| $693K | 0.01% |
20,858
+2,734
| +15% | +$87.4K |
|
1208
Benchmark Electronics
BHE
$2.91B
| $691K | 0.01% |
34,309
-7,514
| -18% | -$153K |
|
1209
AB InBev
BUD
$158B
| $686K | 0.01% |
12,725
-3,806
| -23% | -$211K |
|
1210
Griffon
GFF
$4.16B
| $685K | 0.01% |
+35,043
| New | +$720K |
|
1211
Marriott Vacations Worldwide
VAC
$3.24B
| $685K | 0.01% |
7,544
+1,379
| +22% | +$125K |
|
1212
Kura Oncology
KURA
$922M
| $683K | 0.01% |
22,292
-30,731
| -58% | -$679K |
|
1213
Starwood Property Trust
STWD
$6.12B
| $683K | 0.01% |
45,251
-69,428
| -61% | -$1.06M |
|
|
MYOK
1214
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $683K | 0.01% |
5,013
-19,914
| -80% | -$2.12M |
|
|
TTOO
1215
DELISTED
T2 Biosystems, Inc
TTOO
| $679K | 0.01% |
100
+39
| +64% | +$289K |
|
1216
Cabot Corp
CBT
$4.65B
| $678K | 0.01% |
18,829
-5,449
| -22% | -$207K |
|
1217
Wabash National
WNC
$543M
| $676K | 0.01% |
56,533
-26,842
| -32% | -$316K |
|
1218
Astec Industries
ASTE
$1.3B
| $672K | 0.01% |
12,396
+717
| +6% | +$35.9K |
|
1219
Takeda Pharmaceutical
TAK
$55.1B
| $668K | 0.01% |
+37,434
| New | +$682K |
|
1220
Cooper-Standard Automotive
CPS
$504M
| $667K | 0.01% |
+50,469
| New | +$702K |
|
1221
Everest Group
EG
$15.2B
| $667K | 0.01% |
3,379
-3,909
| -54% | -$837K |
|
1222
Gates Industrial Corporation Ltd.
GTES
$6.81B
| $665K | 0.01% |
+59,792
| New | +$667K |
|
1223
Blackbaud
BLKB
$1.5B
| $664K | 0.01% |
+11,899
| New | +$713K |
|
1224
Gaming and Leisure Properties
GLPI
$12.8B
| $663K | 0.01% |
17,953
-24,242
| -57% | -$882K |
|
1225
Element Solutions
ESI
$9.12B
| $661K | 0.01% |
62,906
-7,033
| -10% | -$77.1K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.